CGTN sits down with Yin Ye, CEO of BGI Group, to explore how breaking cross-industry barriers and leveraging AI are driving a genuine paradigm shift in life sciences. As technology drives the transition from "one-size-fits-all" to personalized medicine, China's proactive, "prevention-first" philosophy is going global. Shifting the gateway from treatment to early screening is not only central to the Healthy China 2030 vision, but also a crucial, unavoidable roadmap for the world to tackle the challenge of an aging society.
Executive producer: Zhang Jingwen
Producer: Yang Sha
Journalist and editor: Zhang Yuying
Copy editors: Wang Dewei, John Goodrich
Cameramen: Guo Wei, Ren Zhong'an, Zhang Shizhe
Cover: Li Yueyun
CHOOSE YOUR LANGUAGE
互联网新闻信息许可证10120180008
Disinformation report hotline: 010-85061466